Looks like you clickedhttps://investors.januxrx.com/news/news-details/2022/Janux-Therapeutics-Announces-FDA-Clearance-of-Investigational-New-Drug-Application-for-JANX007-a-PSMA-TRACTr-for-Metastatic-Castration-Resistant-Prostate-Cancer/default.aspx#:~:text=%E2%80%9CJANX007%20is%20uniquely%20designed%20to,higher%20concentration%20of%20active%20drug
If you do not want to visit that page, you can close this browser tab.
